Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Full Year 2024 Revenue Growth of 28% Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS
Xtant Medical Reports Third Quarter 2024 Financial Results
Third Quarter Revenue Growth of 12% Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 Million Representing Growth of 27% to 31% BELGRADE,
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
BELGRADE, MT / ACCESSWIRE / November 11, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
BELGRADE, MT / ACCESSWIRE / November 7, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
BELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leading global medical technology company focused on the treatment of
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
BELGRADE, MT / ACCESSWIRE / September 18, 2024 /) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT, May 15, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
BELGRADE, Mont. , May 13, 2024 — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
BELGRADE, Mont. , April 30, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Establishes Full Year 2024 Revenue Guidance of $112 Million – $116 Million BELGRADE, Mont. , April 01, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc.
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
BELGRADE, Mont. , March 21, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions